CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ALXO — Alx Oncology Holdings Inc
CIK 884546
SAN FRANCISCO, CA
Position in ALXO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$499,103
+$443,729 QoQ
Shares Held
241,113
+80.7% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 94 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ALXO ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ALXO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $499,103 | 241,113 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $55,374 | 133,433 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $131,484 | 211,051 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $361,900 | 216,707 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $410,049 | 225,302 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,423,200 | 236,020 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,338,812 | 209,759 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,099,561 | 208,164 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $675,523 | 140,734 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,243,288 | 165,551 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $680,133 | 150,472 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,803,030 | 159,985 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,449,874 | 151,502 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,227,358 | 151,713 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,255,795 | 133,479 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,006,064 | 139,882 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,244,825 | 138,706 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,069,054 | 92,704 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,708,127 | 90,970 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,209,072 | 72,031 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,186,051 | 57,924 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||